Brief: Nextcure Presents Biomarker Data And Updated Clinical Results From Phase 1 Portion Of Its Nc318 Clinical Trial

NextCure

29/05/2020 13:54

May 29 (Reuters) - NextCure Inc  NXTC.O :
    * NEXTCURE PRESENTS BIOMARKER DATA AND UPDATED CLINICAL
RESULTS
FROM PHASE 1 PORTION OF ITS NC318 CLINICAL TRIAL AT THE 2020
VIRTUAL AMERICAN SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING
    * NEXTCURE INC - EARLY BIOMARKER DATA SUGGEST COLLECTIVELY
POTENTIAL OF NC318 TO BLOCK S15-MEDIATED IMMUNE SUPPRESSION
    * NEXTCURE INC - EARLY BIOMARKER DATA SUGGEST INCREASE OF
PD-1
EXPRESSION ON CIRCULATING CD4+ T CELLS WHILE ON TREATMENT

Source text for Eikon:  ID:nGNX9yxBRQ 
Further company coverage:  NXTC.O 

 ((Reuters.Briefs@thomsonreuters.com;))